世界のがん幹細胞市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV11232)
◆英語タイトル:Global Cancer Stem Cell Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV11232
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:92
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはがん幹細胞の世界市場について調査・分析した資料です。種類別(細胞培養、細胞分離、細胞分析、分子分析、その他)の市場規模、用途別(幹細胞ベース癌治療、標的CSC)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別がん幹細胞の競争状況、市場シェア
・世界のがん幹細胞市場:種類別市場規模 2015年-2020年(細胞培養、細胞分離、細胞分析、分子分析、その他)
・世界のがん幹細胞市場:種類別市場規模予測 2021年-2026年(細胞培養、細胞分離、細胞分析、分子分析、その他)
・世界のがん幹細胞市場:用途別市場規模 2015年-2020年(幹細胞ベース癌治療、標的CSC)
・世界のがん幹細胞市場:用途別市場規模予測 2021年-2026年(幹細胞ベース癌治療、標的CSC)
・北米のがん幹細胞市場分析:米国、カナダ
・ヨーロッパのがん幹細胞市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのがん幹細胞市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のがん幹細胞市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのがん幹細胞市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Thermo Fisher Scientific, Inc.、AbbVie, Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics, Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics, Inc.、OncoMed Pharmaceuticals, Inc.、Irvine Scientific、STEMCELL Technologies Inc.、Sino Biological Inc.、BIOTIME, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.

Market Analysis and Insights: Global Cancer Stem Cell Market
The global Cancer Stem Cell market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Cancer Stem Cell Scope and Market Size
Cancer Stem Cell market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Stem Cell market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.

Market segment by Type, the product can be split into
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others
Market segment by Application, split into
Stem Cell Based Cancer Therapy
Targeted CSCs

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Stem Cell Revenue
1.4 Market by Type
1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Market Share by Application: 2020 VS 2026
1.5.2 Stem Cell Based Cancer Therapy
1.5.3 Targeted CSCs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cancer Stem Cell Market Perspective (2015-2026)
2.2 Global Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Stem Cell Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Stem Cell Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Stem Cell Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Stem Cell Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cancer Stem Cell Players by Market Size
3.1.1 Global Top Cancer Stem Cell Players by Revenue (2015-2020)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Stem Cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Stem Cell Market Concentration Ratio
3.2.1 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Stem Cell Revenue in 2019
3.3 Cancer Stem Cell Key Players Head office and Area Served
3.4 Key Players Cancer Stem Cell Product Solution and Service
3.5 Date of Enter into Cancer Stem Cell Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cancer Stem Cell Historic Market Size by Type (2015-2020)
4.2 Global Cancer Stem Cell Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cancer Stem Cell Market Size by Application (2015-2020)
5.2 Global Cancer Stem Cell Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cancer Stem Cell Market Size (2015-2020)
6.2 Cancer Stem Cell Key Players in North America (2019-2020)
6.3 North America Cancer Stem Cell Market Size by Type (2015-2020)
6.4 North America Cancer Stem Cell Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cancer Stem Cell Market Size (2015-2020)
7.2 Cancer Stem Cell Key Players in Europe (2019-2020)
7.3 Europe Cancer Stem Cell Market Size by Type (2015-2020)
7.4 Europe Cancer Stem Cell Market Size by Application (2015-2020)

8 China
8.1 China Cancer Stem Cell Market Size (2015-2020)
8.2 Cancer Stem Cell Key Players in China (2019-2020)
8.3 China Cancer Stem Cell Market Size by Type (2015-2020)
8.4 China Cancer Stem Cell Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cancer Stem Cell Market Size (2015-2020)
9.2 Cancer Stem Cell Key Players in Japan (2019-2020)
9.3 Japan Cancer Stem Cell Market Size by Type (2015-2020)
9.4 Japan Cancer Stem Cell Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cancer Stem Cell Market Size (2015-2020)
10.2 Cancer Stem Cell Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Stem Cell Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Stem Cell Market Size by Application (2015-2020)

11 India
11.1 India Cancer Stem Cell Market Size (2015-2020)
11.2 Cancer Stem Cell Key Players in India (2019-2020)
11.3 India Cancer Stem Cell Market Size by Type (2015-2020)
11.4 India Cancer Stem Cell Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cancer Stem Cell Market Size (2015-2020)
12.2 Cancer Stem Cell Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Stem Cell Market Size by Type (2015-2020)
12.4 Central & South America Cancer Stem Cell Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Thermo Fisher Scientific, Inc.
13.1.1 Thermo Fisher Scientific, Inc. Company Details
13.1.2 Thermo Fisher Scientific, Inc. Business Overview
13.1.3 Thermo Fisher Scientific, Inc. Cancer Stem Cell Introduction
13.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2015-2020))
13.1.5 Thermo Fisher Scientific, Inc. Recent Development
13.2 AbbVie, Inc.
13.2.1 AbbVie, Inc. Company Details
13.2.2 AbbVie, Inc. Business Overview
13.2.3 AbbVie, Inc. Cancer Stem Cell Introduction
13.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.2.5 AbbVie, Inc. Recent Development
13.3 Merck KGaA
13.3.1 Merck KGaA Company Details
13.3.2 Merck KGaA Business Overview
13.3.3 Merck KGaA Cancer Stem Cell Introduction
13.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2015-2020)
13.3.5 Merck KGaA Recent Development
13.4 Bionomics
13.4.1 Bionomics Company Details
13.4.2 Bionomics Business Overview
13.4.3 Bionomics Cancer Stem Cell Introduction
13.4.4 Bionomics Revenue in Cancer Stem Cell Business (2015-2020)
13.4.5 Bionomics Recent Development
13.5 Lonza
13.5.1 Lonza Company Details
13.5.2 Lonza Business Overview
13.5.3 Lonza Cancer Stem Cell Introduction
13.5.4 Lonza Revenue in Cancer Stem Cell Business (2015-2020)
13.5.5 Lonza Recent Development
13.6 Stemline Therapeutics, Inc.
13.6.1 Stemline Therapeutics, Inc. Company Details
13.6.2 Stemline Therapeutics, Inc. Business Overview
13.6.3 Stemline Therapeutics, Inc. Cancer Stem Cell Introduction
13.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.6.5 Stemline Therapeutics, Inc. Recent Development
13.7 Miltenyi Biotec
13.7.1 Miltenyi Biotec Company Details
13.7.2 Miltenyi Biotec Business Overview
13.7.3 Miltenyi Biotec Cancer Stem Cell Introduction
13.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2015-2020)
13.7.5 Miltenyi Biotec Recent Development
13.8 PromoCell GmbH
13.8.1 PromoCell GmbH Company Details
13.8.2 PromoCell GmbH Business Overview
13.8.3 PromoCell GmbH Cancer Stem Cell Introduction
13.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2015-2020)
13.8.5 PromoCell GmbH Recent Development
13.9 MacroGenics, Inc.
13.9.1 MacroGenics, Inc. Company Details
13.9.2 MacroGenics, Inc. Business Overview
13.9.3 MacroGenics, Inc. Cancer Stem Cell Introduction
13.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.9.5 MacroGenics, Inc. Recent Development
13.10 OncoMed Pharmaceuticals, Inc.
13.10.1 OncoMed Pharmaceuticals, Inc. Company Details
13.10.2 OncoMed Pharmaceuticals, Inc. Business Overview
13.10.3 OncoMed Pharmaceuticals, Inc. Cancer Stem Cell Introduction
13.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
13.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
13.11 Irvine Scientific
10.11.1 Irvine Scientific Company Details
10.11.2 Irvine Scientific Business Overview
10.11.3 Irvine Scientific Cancer Stem Cell Introduction
10.11.4 Irvine Scientific Revenue in Cancer Stem Cell Business (2015-2020)
10.11.5 Irvine Scientific Recent Development
13.12 STEMCELL Technologies Inc.
10.12.1 STEMCELL Technologies Inc. Company Details
10.12.2 STEMCELL Technologies Inc. Business Overview
10.12.3 STEMCELL Technologies Inc. Cancer Stem Cell Introduction
10.12.4 STEMCELL Technologies Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.12.5 STEMCELL Technologies Inc. Recent Development
13.13 Sino Biological Inc.
10.13.1 Sino Biological Inc. Company Details
10.13.2 Sino Biological Inc. Business Overview
10.13.3 Sino Biological Inc. Cancer Stem Cell Introduction
10.13.4 Sino Biological Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.13.5 Sino Biological Inc. Recent Development
13.14 BIOTIME, Inc.
10.14.1 BIOTIME, Inc. Company Details
10.14.2 BIOTIME, Inc. Business Overview
10.14.3 BIOTIME, Inc. Cancer Stem Cell Introduction
10.14.4 BIOTIME, Inc. Revenue in Cancer Stem Cell Business (2015-2020)
10.14.5 BIOTIME, Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Thermo Fisher Scientific, Inc.、AbbVie, Inc.、Merck KGaA、Bionomics、Lonza、Stemline Therapeutics, Inc.、Miltenyi Biotec、PromoCell GmbH、MacroGenics, Inc.、OncoMed Pharmaceuticals, Inc.、Irvine Scientific、STEMCELL Technologies Inc.、Sino Biological Inc.、BIOTIME, Inc.

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがん幹細胞市場2026:インサイト・予測(Global Cancer Stem Cell Market Size, Status and Forecast 2020-2026)]についてメールでお問い合わせはこちらでお願いします。